Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.
Regulatory T cells (T(regs)) manipulated ex vivo have potential as cellular therapeutics in autoimmunity and transplantation. Although it is possible to expand naturally occurring T(regs), an attractive alternative possibility, particularly suited to solid organ and bone marrow transplantation, is t...
主要な著者: | Feng, G, Nadig, SN, Bäckdahl, L, Beck, S, Francis, R, Schiopu, A, Whatcott, A, Wood, K, Bushell, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
類似資料
-
Cyclic nucleotide phosphodiesterases in health and disease /
著者:: Beavo, Joe, 等
出版事項: (2007) -
Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
著者:: Issa, F, 等
出版事項: (2010) -
A brief in vitro activation is sufficient to equip naturally-occurring regulatory T Cells to control allograft rejection long-term
著者:: Chan, T, 等
出版事項: (2014) -
Cyclic nucleotide specific phosphodiesterases of <it>Leishmania major</it>
著者:: Linder Markus, 等
出版事項: (2006-03-01) -
Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
著者:: Rahul Mittal, 等
出版事項: (2017-11-01)